BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 9089330)

  • 1. Preparation, DNA binding, and in vitro cytotoxicity of a pair of enantiomeric platinum(II) complexes, [(R)- and (S)-3-aminohexahydroazepine]dichloroplatinum(II). Crystal structure of the S enantiomer.
    Fenton RR; Easdale WJ; Er HM; O'Mara SM; McKeage MJ; Russell PJ; Hambley TW
    J Med Chem; 1997 Mar; 40(7):1090-8. PubMed ID: 9089330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation, characterization, DNA binding, and in vitro cytotoxicity of the enantiomers of the platinum(II) complexes N-methyl-, N-ethyl- and N,N-dimethyl-(R)- and -(S)-3-aminohexahydroazepinedichloroplatinum(II).
    Rezler EM; Fenton RR; Esdale WJ; McKeage MJ; Russell PJ; Hambley TW
    J Med Chem; 1997 Oct; 40(22):3508-15. PubMed ID: 9357517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA adducts of the enantiomers of the Pt(II) complexes of the ahaz ligand (ahaz=3-aminohexahydroazepine) and recognition of these adducts by HMG domain proteins.
    Malina J; Vojtiskova M; Brabec V; Diakos CI; Hambley TW
    Biochem Biophys Res Commun; 2005 Jul; 332(4):1034-41. PubMed ID: 15922304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enantioselectivity and stereoselectivity in the reactions of the enantiomers of the platinum complex [PtCl2(ahaz)] (ahaz=3(R)- or 3(S)-aminohexahydroazepine) with DNA.
    Er HM; Hambley TW
    J Inorg Biochem; 2009 Feb; 103(2):168-73. PubMed ID: 19000939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and X-ray crystal structure of trans,cis-[Pt(OAc)2I2(en)]: a novel type of cisplatin analog that can be photolyzed by visible light to DNA-binding and cytotoxic species in vitro.
    Kratochwil NA; Zabel M; Range KJ; Bednarski PJ
    J Med Chem; 1996 Jun; 39(13):2499-507. PubMed ID: 8691447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chiral platinum(II) metallointercalators with potent in vitro cytotoxic activity.
    Fisher DM; Bednarski PJ; Grünert R; Turner P; Fenton RR; Aldrich-Wright JR
    ChemMedChem; 2007 Apr; 2(4):488-95. PubMed ID: 17340669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Model platinum nucleobase and nucleoside complexes and antitumor activity: X-ray crystal structure of [PtIV(trans-1R,2R-diaminocyclohexane)trans-(acetate)2(9-ethylguanine)Cl]NO3.H2O.
    Ali MS; Khan SR; Ojima H; Guzman IY; Whitmire KH; Siddik ZH; Khokhar AR
    J Inorg Biochem; 2005 Mar; 99(3):795-804. PubMed ID: 15708801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of cytotoxicity and cellular pharmacology of 1,2-diaminocyclohexane platinum (IV) complexes mediated by axial and equatorial ligands.
    Kido Y; Khokhar AR; al-Baker S; Siddik ZH
    Cancer Res; 1993 Oct; 53(19):4567-72. PubMed ID: 8402629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification by NMR spectroscopy of the two stereoisomers of the platinum complex [PtCl2(S-ahaz)] (S-ahaz = 3(S)-aminohexahydroazepine) bound to a DNA 14-mer oligonucleotide. NMR evidence of structural alteration of a platinated A x T-rich 14-mer DNA duplex.
    Diakos CI; Messerle BA; Murdoch Pdel S; Parkinson JA; Sadler PJ; Fenton RR; Hambley TW
    Inorg Chem; 2009 Apr; 48(7):3047-56. PubMed ID: 19265406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies of the mechanism of action of platinum(II) complexes with potent cytotoxicity in human cancer cells.
    Krause-Heuer AM; Grünert R; Kühne S; Buczkowska M; Wheate NJ; Le Pevelen DD; Boag LR; Fisher DM; Kasparkova J; Malina J; Bednarski PJ; Brabec V; Aldrich-Wright JR
    J Med Chem; 2009 Sep; 52(17):5474-84. PubMed ID: 19658404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, crystal structure, cytotoxic activity and DNA-binding properties of the copper (II) and zinc (II) complexes with 1-[3-(2-pyridyl)pyrazol-1-ylmethyl]naphthalene.
    Zhang H; Liu CS; Bu XH; Yang M
    J Inorg Biochem; 2005 May; 99(5):1119-25. PubMed ID: 15833335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, crystal structure, studies in solution and cytotoxicity of two new fluorescent platinum(II) compounds containing anthracene derivatives as a carrier ligand.
    Marqués-Gallego P; den Dulk H; Brouwer J; Kooijman H; Spek AL; Roubeau O; Teat SJ; Reedijk J
    Inorg Chem; 2008 Dec; 47(23):11171-9. PubMed ID: 18975941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, in vitro cytotoxic and antiviral activity of cis-[Pt(R(-) and S(+)-2-alpha-hydroxybenzylbenzimidazole)2Cl2] complexes.
    Gökçe M; Utku S; Gür S; Ozkul A; Gümüş F
    Eur J Med Chem; 2005 Feb; 40(2):135-41. PubMed ID: 15694648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, characterisation and in vitro cytotoxicity studies of a series of chiral platinum(II) complexes based on the 2-aminomethylpyrrolidine ligand: X-ray crystal structure of [PtCl2(R-dimepyrr)] (R-dimepyrr=N-dimethyl-2(R)-aminomethylpyrrolidine).
    Diakos CI; Zhang M; Beale PJ; Fenton RR; Hambley TW
    Eur J Med Chem; 2009 Jul; 44(7):2807-14. PubMed ID: 19185955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structures and cytotoxicity of isopropylamine Pt(II) complexes: a trinuclear squarato-bridged [Pt3(mu2-C4O4)3(H2NPri)6].3H2O and a mononuclear cis-[Pt(NO3)2(H2NPri)2].
    Grabner S; Modec B; Cemazar M; Bukovec N
    J Inorg Biochem; 2005 Jul; 99(7):1465-71. PubMed ID: 15927264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation, characterization, cytotoxicity, and mutagenicity of a pair of enantiomeric platinum(II) complexes with the potential to bind enantioselectively to DNA.
    Vickery K; Bonin AM; Fenton RR; O'Mara S; Russell PJ; Webster LK; Hambley TW
    J Med Chem; 1993 Nov; 36(23):3663-8. PubMed ID: 8246235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytotoxic effects of gold(III) complexes on established human tumor cell lines sensitive and resistant to cisplatin.
    Calamai P; Carotti S; Guerri A; Mazzei T; Messori L; Mini E; Orioli P; Speroni GP
    Anticancer Drug Des; 1998 Jan; 13(1):67-80. PubMed ID: 9474243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, characterization and antiproliferative studies of the enantiomers of cis-[(1,2-camphordiamine)dichloro]platinum(II) complexes.
    Montaña AM; Bernal FJ; Lorenzo J; Farnós C; Batalla C; Prieto MJ; Moreno V; Avilés FX; Mesas JM; Alegre MT
    Bioorg Med Chem; 2008 Feb; 16(4):1721-37. PubMed ID: 18036822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substituted beta-cyclodextrin and calix[4]arene as encapsulatory vehicles for platinum(II)-based DNA intercalators.
    Krause-Heuer AM; Wheate NJ; Tilby MJ; Pearson DG; Ottley CJ; Aldrich-Wright JR
    Inorg Chem; 2008 Aug; 47(15):6880-8. PubMed ID: 18597414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of transcription in vitro by anticancer active dirhodium(II) complexes.
    Sorasaenee K; Fu PK; Angeles-Boza AM; Dunbar KR; Turro C
    Inorg Chem; 2003 Feb; 42(4):1267-71. PubMed ID: 12588165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.